Browsing Tag
DF-003
2 posts
Drug Farm advances DF-003 into FDA rare disease evidence pathway as ROSAH syndrome program enters regulatory dialogue phase
Drug Farm’s DF-003 enters the FDA Rare Disease Evidence Principles Process for ROSAH syndrome. Discover why this regulatory collaboration could shape rare disease drug development.
Drug Farm’s DF-003 gets FDA rare pediatric disease designation for ROSAH Syndrome
Drug Farm, a clinical-stage biopharmaceutical company, has announced that its alpha-kinase 1 (ALPK1) inhibitor, DF-003, has been granted…